Related Experiment Video

Updated: Apr 4, 2026

Real Time Detection of In Vitro Tumor Cell Apoptosis Induced by CD8+ T Cells to Study Immune Suppressive Functions of Tumor-infiltrating Myeloid Cells
09:57

Real Time Detection of In Vitro Tumor Cell Apoptosis Induced by CD8+ T Cells to Study Immune Suppressive Functions of Tumor-infiltrating Myeloid Cells

Published on: January 29, 2019

23.6K

CD8⁺ T Cell-Independent Immune-Mediated Mechanisms of Anti-Tumor Activity

G Elizabeth Pluhar1, Christopher A Pennell2, Michael R Olin3

  • 1Department of Veterinary Clinical Sciences, College of Veterinary Medicine, University of Minnesota, St. Paul, MN. 55108.

Critical Reviews in Immunology
|September 10, 2015
PubMed

Insights

Despite advances in immunotherapy for malignant gliomas, treatment outcomes remain poor. This review explores immune mechanisms beyond CD8+ T cells for effective tumor clearance, guiding future glioma therapy designs.

Area of Science:

  • Neuro-oncology
  • Immunology
  • Cancer Research

Background:

  • Malignant gliomas have a poor prognosis despite increasing immunotherapy trials.
  • Cancer immunotherapy aims to harness the immune system for tumor cell elimination.
  • Current cancer vaccines show limited efficacy due to incomplete understanding of effector mechanisms.

Purpose of the Study:

  • To review the mechanisms of effective anti-tumor immune responses.
  • To guide future therapeutic designs for malignant gliomas.
  • To explore alternative immune-mediated tumor clearance mechanisms beyond CD8+ T cells.

Main Methods:

  • Literature review of preclinical and clinical studies on glioma immunotherapy.
  • Analysis of immune cell functions in tumor eradication.
  • Synthesis of evidence on non-CD8+ T cell mediated anti-tumor activity.

Main Results:

  • CD8+ T cell cytotoxic activity is traditionally viewed as the primary mechanism for tumor regression.
  • Emerging evidence highlights the significant roles of other immune components in tumor control.
  • Understanding these alternative mechanisms is crucial for improving therapeutic strategies.

Conclusions:

  • Effective anti-tumor responses involve complex immune interactions beyond CD8+ T cells.
  • Alternative immune mechanisms offer promising avenues for novel malignant glioma therapies.
  • Further research into these pathways can optimize immunotherapy design for better patient outcomes.

More Related Videos

Tumor Transplantation for Assessing the Dynamics of Tumor-Infiltrating CD8+ T Cells in Mice07:36

Tumor Transplantation for Assessing the Dynamics of Tumor-Infiltrating CD8+ T Cells in Mice

Published on: June 12, 2021

7.9K
Analysis of Human T Cell Activity in an Allogeneic Co-Culture Setting of Pre-Treated Tumor Cells09:04

Analysis of Human T Cell Activity in an Allogeneic Co-Culture Setting of Pre-Treated Tumor Cells

Published on: March 7, 2025

1.9K

Related Concept Videos

Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
2.3K
Cytotoxic T Cells-mediated Immune Response01:27

Cytotoxic T Cells-mediated Immune Response

Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
8.3K
The Tumor Microenvironment02:17

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
8.2K
Cell-mediated Immune Responses01:40

Cell-mediated Immune Responses

Overview
86.5K
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
6.2K
T Cell Activation and Clonal Selection01:22

T Cell Activation and Clonal Selection

T cells are integral to our adaptive immune system, recognizing and effectively responding to foreign antigens. T cell activation and clonal selection are pivotal in orchestrating this immune response. This article elucidates these mechanisms, detailing the roles of cluster of differentiation (CD) markers, major histocompatibility complex (MHC) molecules, costimulatory signals, and the process of clonal selection.
Naive T cells that have not yet encountered an antigen express two primary CD...
17.5K